|
LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma30 Jan 2023
BOCA RATON, Fla.–(BUSINESS WIRE)– LGM Pharma today announced that it has acquired the formulation development and drug product contract manufacturing... Continue Reading
|
|
Nemaura Enters into Letter of Intent to Acquire Healthimation, LLC to Augment proBEAT™ Launch in the U.S.30 Jan 2023
LOUGHBOROUGH, England–(BUSINESS WIRE)– Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based... Continue Reading
|
|
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific30 Jan 2023
Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and development Establishes large footprint... Continue Reading
|
|
Emergent Executes “Letter of Intent” to Acquire Nanosthetic, a Biologics Company That Manufacturers Products to be Sold and Marketed by Evolutionary Biologics30 Jan 2023
NEW YORK, NY / ACCESSWIRE / January 26, 2023 / Emergent Health Corp. (OTC PINK:EMGE), a curator, developer and marketer... Continue Reading
|
|
Quince Therapeutics Completes the Sale of Legacy Protease Inhibitor Portfolio to Lighthouse Pharmaceuticals30 Jan 2023
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Quince Therapeutics Inc. (Nasdaq: QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and... Continue Reading
|
|
Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders30 Jan 2023
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company’s confidence in, and commitment... Continue Reading
|
|
Sona Nanotech to Acquire Cancer Therapy Developer Siva Therapeutics30 Jan 2023
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021... Continue Reading
|
|
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank30 Jan 2023
SAN DIEGO & HAMBURG, Germany–(BUSINESS WIRE)– Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company,... Continue Reading
|
|
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII30 Jan 2023
CORAL GABLES, Fla., Jan. 25, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused... Continue Reading
|
|
Kroger Health launches clinical trial site network30 Jan 2023
Kroger Health, the healthcare division of the large grocery chain, announced Tuesday it had launched a clinical trial site network.... Continue Reading
|